Bibliography

Manuscripts published or in press

  1. Krebs DW, Chi BH, Mulenga Y, Morris M, Cantrell RA, Mulenga L, Levy J, Sinkala M, Stringer JSA. Community-based follow-up for late patients enrolled in a district-wide program for antiretroviral therapy in Lusaka, Zambia. AIDS Care; in press.
  2. Chi BH, Wang L, Read JS, Taha TE, Sinkala M, Brown ER, Valentine M, Martinson F, Goldenberg RL. Predictors of stillbirth in sub-Saharan Africa: HPTN 024. Obstet Gynecol; in press.
  3. Stringer EM, Chi BH, Chintu N, Creek T, Ekouvie D, Coetzee D, Tih P, Boulle A, Dabis F, Shaffer N, Wilfert CM, Stringer JSA. Monitoring effectiveness of programs to prevent mother-to-child HIV transmission in lower-income countries. Bull World Health Organ, in press.
  4. Stringer EM, Kaseba C, Levy J, Sinkala M, Goldenberg RL, Chi BH, Matongo I, Vermund SH, Mwanahamuntu M, Stringer JSA. A randomized trial of the intrauterine contraceptive device (IUD) versus hormonal contraception in HIV-infected women. Am J Obstet Gynecol; in press.
  5. Sahasrabuddhe VV, Mwanahamuntu MH, Vermund SH, Huh WK, Lyon MD, Stringer JS, Parham GP. Prevalence and distribution of HPV-genotyping among HIV-infected women in Zambia. Br J Cancer 2007; 96(9): 1480-3.
  6. Chi BH, Sinkala M, Stringer EM, Cantrell RA, Mtonga V, Bulterys M, Zulu I, Kankasa C, Wilfert C, Weidle PJ, Vermund SH, Stringer JSA. Early clinical and immune response to NNRTI-based antiretroviral therapy among women exposed to single-dose nevirapine for prevention of mother-to-child HIV transmission. AIDS 2007; 21:957-64.
  7. Chi BH, Chintu N, Lee A, Stringer EM, Sinkala M, Stringer JSA. Expanded services for the prevention of mother-to-child HIV transmission: field acceptability of a pilot program in Lusaka, Zambia. J Acquir Immune Defic Syndr 2007; 45:125-7.
  8. Banda Y, Chapman V, Goldenberg RL, Chi BH, Vermund SH, Stringer JSA. Influence of BMI on pregnancy outcomes of HIV-infected and -uninfected Zambian women. Trop Med Int Health 2007; 12: 856-61.
  9. MacQueen KM, Namey E, Chilongozi DA, Mtweve SP, Mlingo M, Morar N, Reid C, Ristow A, Sahay S. Community perspectives on care options for HIV prevention trial participants. AIDS Care 2007; 19: 554 – 60.
  10. Banda Y, Chapman V, Goldenberg RL, Stringer JSA, Culhane JF, Sinkala M, Vermund SH, Chi BH. Use of traditional medicines among pregnant women in Lusaka, Zambia. J Altern Complement Med 2007; 13: 123 – 8.
  11. Brahmi A, Reid C, Masse B, Kelly C. Meeting retention challenges in Lusaka, Zambia. Research Practitioner 2006; 7: 212-13.
  12. Bagchi S, Kempf MC, Westfall AO, Maherya A, Willig J, Saag MSS. Can routine clinical markers be used longitudinally to monitor antiretroviral therapy success in resource limited settings? Clin Inf Dis 2007; 44:135-8.
  13. Chi BH, Lee A, Acosta EP, Westerman LE, Sinkala M, Stringer JSA. Field validation of a thin-layer chromatography assay for detection of nevirapine in umbilical cord blood. HIV Clinical Trials 2006; 7: 263-269.
  14. Parham GP, Sahasrabuddhe VV, Mwanahamuntu MH, Shepherd BE, Hicks ML, Stringer EM, Vermund SH. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. Gynecol Oncol 2006; 103: 1017-22.
  15. Stringer JSA, Zulu I, Levy J, Stringer EM, Mwango A, Chi BH, Mtonga V, Reid S, Cantrell RA, Bulterys M, Saag MS, Marlink RG, Mwinga A, Ellerbrock TV, Sinkala M. Rapid scale-up of antiretroviral therapy at primary care sites in Lusaka, Zambia: feasibility and early outcomes; JAMA 2006; 296: 782-93.
  16. Goldenberg RL, Mudenda V, Read JS, Brown ER, Sinkala M, Kamiza S, Martinson F, Kaaya E, Hoffman I, Fawzi W, Valentine M, Taha TE. HPTN 024 study: histologic chorioamnionitis, antibiotics, and adverse infant outcomes in a predominantly HIV-1-infected African population; Am J Obstet Gynecol 2006; 195: 1065-74.
  17. Thierman S, Chi BH, Levy JW, Sinkala M, Goldenberg RL, Stringer JSA. Individual-level predictors for HIV testing among antenatal attendees in Lusaka, Zambia; Am J Med Sci 2006; 332: 13-17.
  18. Taha TE, Brown ER, Hoffman IF, Fawzi W, Read JS, Sinkala M, Martinson FE, Kafulafula G, Msamanga G, Emel L, Adeniyi-Jones S, Goldenberg RL. A phase III clinical trial of antibiotics to reduce chorioamnionitis-related perinatal HIV-1 transmission. AIDS 2006; 20: 1313-21.
  19. Potter D, Goldenberg RL, Read JS, Hoffman IF, Saathoff E, Kafulafula G, Aboud S, Martinson FE, Dahab M, Vermund SH. Correlates of syphilis seroreactivity among pregnant women: the HIVNET 024 trial in Malawi, Tanzania, and Zambia. Sex Transm Dis 2006;33: 604-9.
  20. Chi BH, Fusco H, Goma FM, Zulu I, Simmers E, Stringer JSA. HIVCorps: using volunteers to rapidly expand HIV health services across Zambia; Am J Trop Med Hyg 2006; 74: 918-21.
  21. Goldenberg RL, Mwatha A, Read JS, Adeniyi-Jones S, Sinkala M, Msmanga G, Martinson F, Hoffman I, Fawzi W, Valentine M, Emel L, Brown E, Mudenda V, Taha TE. The HPTN 024 Study: the efficacy of antibiotics to prevent chorioamnionitis and preterm birth. Am J Obstet Gynecol 2006; 194: 650-61.
  22. Chi BH, Mudenda V, Levy J, Sinkala M, Goldenberg RL, Stringer JSA. Acute and chronic chorioamnionitis and the risk of perinatal HIV-1 transmission. Am J Obstet Gynecol 2005; 194:174-81.
  23. Chi BH, Sinkala M, Stringer EM, McFarlane YA, Ng’uni C, Myzece E, Goldenberg RL, Stringer JSA. Employment of off-duty staff: a strategy to meet the human resource of a large PMTCT program in Zambia. J Acquir Immune Defic Syndr 2005; 40: 381-82.
  24. Chi BH, Fusco H, Sinkala M, Goldenberg RL, Stringer, JSA. Cost and enrollment implications of targeting different source population for an HIV treatment program. J Acquir Immune Defic Syndr 2005; 40: 350-55.
  25. Chi BH, Wang L, Read JS, Sheriff M, Fiscus S, Brown E, Valentine M, Goldenberg RL. Timing of maternal and neonatal dosing of nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024; AIDS 2005; 19: 1857-1864.
  26. Maclean CC, Stringer JS. Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent mother-to-child transmission during breast-feeding. J Acquir Immune Defic Syndr 2005;38(5):570-577.
  27. Stringer JSA, Sinkala M, Maclean CC, Levy J, Kankasa C, DeGroot A, Stringer EM, Acosta EP, Goldenberg RL, Vermund SH. Effectiveness of a city-wide program to prevent mother-to-child HIV transmission in Lusaka, Zambia. AIDS 2005; 19:1309-1315.
  28. Modjarrad K, Zulu I, Redden DT, Njobvu L, Lane HC, Bentwich Z, Vermund SH. Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in coinfected Zambian adults. J Infect Dis 2005; 192:1277-83.
  29. Modjarrad K, Zulu I, Redden DT, Njobvu L, Freedman Do, Vermund SH. Prevalence and predicators of intestinal helminth infections among human immunodeficiency virus type 1-infected adults in an urban African setting. Am J Trop Med Hyg 2005; 73: 777-82.
  30. Chi BH, Chansa K, Gardner MO, Sangi-Haghpeykar H, Goldenberg RL, Sinkala M, Muchimba M, Stringer JSA. Perceptions toward HIV, HIV screening, and the use of antiretroviral medications: a survey of maternity-based healthcare providers in Zambia. Int J STD AIDS 2004; 15(10): 685-90.
  31. Reid SE, Reid CA, Vermund SH. Antiretroviral therapy in sub-Saharan Africa: adherence lessons from tuberculosis and leprosy. Int J STD AIDS 2004;15(11):713-6.
  32. Vermund SH. Prevention of mother-to-child transmission of HIV in Africa. Top HIV Med 2004;12(5):130-4
  33. Wilfert CM, Stringer JS. Prevention of pediatric human immunodeficiency virus. Semin Pediatr Infect Dis 2004;15(3):190-8.
  34. Wright RJ, Stringer JS. Rapid testing strategies for HIV-1 serodiagnosis in high-prevalence African settings. Am J Prev Med 2004;27(1):42-8.
  35. Zulu I, Schuman P, Musonda R, et al. Priorities for antiretroviral therapy research in sub-Saharan Africa: A 2002 Consensus Conference in Zambia. J Acquir Immune Defic Syndr 2004;36(3):831-834.
  36. Stringer EM, Sinkala M, Kumwenda R, Chapman V, Mwale A, Vermund SH, Goldenberg RL, Stringer JS. Personal risk perception, HIV knowledge, and risk avoidance behavior, and their relationships to actual HIV serostatus in an urban African obstetric population. J Acquir Immune Defic Syndr 2004; 35(1): 60-6.
  37. Bennetto CJ, King JR, Turner ML, Stringer JS, Acosta EP. Effects of concentration and temperature on the stability of nevirapine in whole blood and serum. Clin Chem 2004;50(1):209-11.
  38. Dubuisson JG, King JR, Stringer JS, Turner ML, Bennetto C, Acosta EP. Detection of nevirapine in plasma using thin-layer chromatography. J Acquir Immune Defic Syndr 2004;35(2):155-7.
  39. Stringer JS, Sinkala M, Goldenberg RL, et al. Universal nevirapine upon presentation in labor to prevent mother-to-child HIV transmission in high prevalence settings. AIDS 2004;18(6):939-43.
  40. Stringer JSA, Sinkala M, Goldenberg R, Vermund S, Acosta E. Monitoring nevirapine-based programmes for prevention of mother-to-child transmission of HIV-1. Lancet 2003; 362(9384): 667.
  41. Stringer JSA, Rouse DJ, Sinkala M, Marseille EA, Vermund SH, Stringer EM, Goldenberg RL. Nevirapine to prevent mother-to-child transmission of HIV-1 among women of unknown serostatus. Lancet 2003: 362 (9398): 1850-3.
  42. Stringer JSA, Sinkala M, Stout JP, Goldenberg RL, Acosta EP, Chapman V, Kumwenda R, Vermund SH. Comparison of two strategies for administering nevirapine to prevent perinatal HIV transmission in high-prevalence, resource-poor settings; J Acquir Immune Defic Syndr 2003, 32: 506-513.
  43. Stringer JSA, Sinkala M, Chapman V, Acosta EP, Goldenberg RL, Stout JP, Vermund SH. Timing of the maternal drug dose and risk of perinatal HIV transmission in the setting of intrapartum and neonatal single-dose nevirapine. AIDS 2003; 17: 1659-65.
  44. Stringer EM, Sinkala M, Stringer JSA, Mzyece E, Makuka I, Goldenberg RL, Kwape P, Chilufya M, Vermund SH. Prevention of mother-to-child transmission of HIV in Africa: successes and challenges in scaling-up a nevirapine-based program in Lusaka, Zambia. AIDS 2003; 17:1377-82.
  45. Sinkala M, Stout JP, Vermund SH, Goldenberg RL, Stringer JSA. Zambian women's attitudes toward mass nevirapine therapy to prevent perinatal transmission of HIV. Lancet 2001;358:1611-12.
  46. Stringer EM, Stringer JSA, Cliver SP, Goldenberg RL, Goepfert AR. Evaluation of a new testing policy for human immunodeficiency virus to improve screening rates. Obstet Gynecol 2001;98(6):1104-8.
  47. Stringer JSA, Sinkala M, Rouse DJ, Goldenberg RL, Vermund SH. Effect of nevirapine toxicity on choice of perinatal HIV prevention strategies. Am J Public Health 2002; 92(3):365-6.
  48. Goldenberg RL, Stringer JS, Sinkala M, Vermund SH. Perinatal HIV transmission: developing country considerations. J Matern Fetal Neonatal Med 2002;12(3):149-58.
  49. Stringer JSA, Rouse DJ, Goldenberg RL, Vermund SH, Stinnett AA. Cost-effective use of perinatal nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr 2000;24(4):369-77.
  50. Stringer JSA, Goldenberg RL. Subclinical chorioamnionitis as a targetable risk factor for perinatal transmission of HIV-1. Ann NY Acad Sci 2000;918:77-83.
  51. Stringer JS, Rouse DJ, Vermund SH, Goldenberg RL, Sinkala M, Stinnett AA. Cost-effective use of nevirapine to prevent vertical HIV transmission in sub-Saharan Africa. J Acquir Immune Defic Syndr 2000;24(4):369-77.
  52. Stringer JSA, Rouse DJ, Goldenberg RL. Prophylactic cesarean for the prevention of perinatal HIV transmission: the case for restraint. JAMA 1999;281(20):1946-9.
  53. Stringer JS, Vermund SH. Prevention of mother-to-child transmission of HIV-1. Curr Opin Obstet Gynecol 1999;11(5):427-34.
  54. Goldenberg RL, Vermund SH, Goepfert AR, Andrews WW. Choriodecidual inflammation: a potentially preventable cause of perinatal HIV-1 transmission? Lancet 1998;352(9144):1927-30.

Abstracts

(* denotes oral presentation)

  1. * Goldman JD, Mumba P, Cantrell RA, Levy J, Limbada M, Morris M, Mulenga L, Reid S, Taylor A, Chi BH, Vermund SH, Stringer JSA. Simple assessments of adherence to antiretroviral therapy predict virologic failure in HIV-infected patients in Lusaka, Zambia. 3rd IAS Conference on HIV Pathogenesis and Treatment, Sydney, Australia, July 22 -25, 2007. Abstract WEAB105.
  2. * Chi B, Sinkala M, Levy J, Stringer E, Bulterys M, Zulu I, Kaseba C, Mtonga V, Wilfert C, Stringer J. Maternal immune response and clinical outcomes on NNRTI-based antiretroviral therapy (ART) following exposure to single-dose nevirapine (NVP) for prevention of mother-to-child HIV transmission (PMTCT). XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract WeAB0104.
  3. * Mbewe M, Bolton C, Levy J, Sinkala M, Bulterys M, Chi B, Wilfert C, Stringer J, Dumas A, Chintu N, Stringer E. Children enrolled in a public HIV care and treatment program in Lusaka, Zambia: rapid scale-up and first-year clinical outcomes. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract MOAB0201.
  4. * Megazzini K, Washington S, Sinkala M, Lawson-Marriott S, Stringer E, Krebs D, Levy J, Chi B, Cantrell R, Zulu I, Mulenga L, Stringer J. A pilot randomized trial of nutritional supplementation in food insecure patients receiving antiretroviral therapy (ART) in Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract MOAB0401.
  5. * Parham G, Sahasrabuddhe V, Vermund S, Shepherd B, Stringer E, Mwanahamuntu M. Prevalence and predictors of squamous intraepithelial lesions of the cervix in HIV-infected women in Lusaka, Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract TUAB0303.
  6. * Jham M, Levy J, Kancheya N, Pankratz D, Kaminsa-Kabanje S, Jurkuvenas V, Kimerling M, Reid S. Screening for tuberculosis (TB) in HIV voluntary counseling and testing (VCT) services in Lusaka, Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract MOKC203.
  7. Mukuka I, Spadoni S, Chirwa S, Banda S, Nakanyika N, Chi B, Bolton C. Clinic-based treatment support groups provide education, family support, empowerment and raise HIV/AIDS awareness in communities in Lusaka, Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract MOPE0936.
  8. Banda S, Sakala S, Banda E, Spadoni S, Makuka I, Chirwa S, Nakanyika N, Chi B, Bolton C. Voluntary HIV counseling and testing (VCT): is it feasible in schools? XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract WEPE0448.
  9. Reid S, Levy J, Jham M, Pankratz D, Kancheya N, Kaminsa-Kabanje S, Jurkuvenas V, Kimerling M. Clinical outcomes among TB/HIV co-infected patients enrolled in antiretroviral therapy (ART) in Lusaka, Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract MOPE0166.
  10. Cantrell R, Chi B, Mulenga L, Sinkala M, Levy J, Stringer E, Reid S, Bulterys M, Zulu I, Stringer J. Incidence and predictors of hepatotoxicity among patients receiving nevirapine (NVP)-containing antiretroviral therapy (ART) in Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract WEPE0172.
  11. Sahasrabuddhe V, Parham G, Manahamuntu M, Mudenda V, Vermund S. Visual inspection with acetic acid (VIA) for cervical cancer screening in HIV-infected Zambian women. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract THPE0193.
  12. Morris M, Bolton C, Mwanza J, Manda H, Gillespie M, Kabeta M, Reid S. Ensuring quality patient care during rapid scale-up of antiretroviral (ARV) therapy in Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract THPE0224.
  13. Dumas SA, Chi B, Mubiana-Mbewe M, Bolton C. Barriers to providing antiretroviral therapy (ART) to HIV-infected children in Lusaka, Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract MOPE0234.
  14. Krebs D, Chi B, Mulenga Y, Cantrell R, Levy J. A community-based contact tracing program for patients enrolled in a district-wide program for antiretroviral therapy (ART). XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract TUPE0143.
  15. Kaminsa-Kabanje S, Jham M, Kancheya N, Jurkuvenas V, Kimerling M, Reid S. Integration of tuberculosis (TB) and HIV care in primary health care services in Lusaka, Zambia. XVI International AIDS Conference, Toronto, Canada, August 13-18, 2006; Abstract MOPE0168.
  16. * Sinkala M, Levy J, Zulu I, Mwango A, Stringer E, Chi B, Reid S, Ellerbrock T, Bulterys M, Stringer J. Rapid scale-up of antiretroviral services in Zambia: 1-year clinical and immunological outcomes. 13th Conference on Retroviruses and Opportunistic Infections in Denver, CO, February 5-8, 2006; Abstract 64.
  17. * Chi BH, Wang L, Read JS, Sheriff M, Fiscus S, Brown E, Valentine M, Adeniyi-Jones S, Goldenberg RL. Timing of maternal and infant nevirapine and the risk of mother-to-child transmission of HIV-1: HIVNET 024. 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July 24-27, 2005; Abstract TuPp0405 (oral poster presentation).
  18. Mazimba C, Collins W, Kaseba C, Chi B. HIV-related maternal mortality in Lusaka, Zambia: 1993-2004. 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July 24-27, 2005; Abstract MoPe11.6C19.
  19. Megazzini K, Chi B, Sinkala M, Stringer J, Vermund S. Single dose nevirapine versus combination zidovudine-nevirapine for PMTCT of HIV: an outcomes-oriented policy review for developing countries. 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July 24-27, 2005; Abstract TuPe5.2P05.
  20. Fusco H, Hubschman T, Mweeta V, Chi B, Levy J, Sinkala M, Stringer J. Electronic patient tracking supports rapid expansion of HIV care and treatment in resource-constrained settings. 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July 24-27, 2005; Abstract MoPe11.2C37.
  21. Reed RC, Heynen AJ, Sinkala M, Stringer JS. Transition to permenance: the organizational transformation of a non-government organization in Lusaka, Zambia. 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July 24-27, 2005; Abstract MoPe11.10C31.
  22. Zachary D, Mweemba A, Helova A, Maphiri F, Sinkala M, Stallworth, J. Beliefs regarding HIV research participation in Lusaka, Zambia. 3rd IAS Conference on HIV Pathogenesis and Treatment. Rio de Janeiro, Brazil, July 24-27, 2005; Abstract TuPe11.9C07.
  23. *Hubschman T, Mweetwa V, Fusco H, Chi B, Levy J, Sinkala M, Shields M, Stringer J. Electronic patient tracking supports rapid expansion of HIV care and treatment in Lusaka, Zambia. President’s Emergency Plan for AIDS Relief 2nd Annual Meeting, “Supporting National Strategies: Building on Success.” Addis Ababa, Ethiopia, May 22-27, 2005.
  24. * Sinkala M, McFarlane Y, N’guni C, Stringer J, Mphanza E, Myceze E, Stringer EM. Scale-up of PMTCT services in Zambia. President’s Emergency Plan for AIDS Relief 2nd Annual Meeting, “Supporting National Strategies: Building on Success.” Addis Ababa, Ethiopia, May 22-27, 2005.
  25. * Parham G, Sahasrabuddhe V, Hicks M, Vermund S, Mwanahamuntu M. Cervical Cancer Screening in HIV-infected Women in Zambia. UAB Minority Health Research Day Conference, Birmingham, AL, April 18, 2005.
  26. Sahasrabuddhe V, Mwanahamuntu M, Hicks M, Vermund S, Parham G. Cervical Cancer Screening in HIV-infected Women in Zambia. 22nd International Papillomavirus Conference and Clinical Workshop, Vancouver, Canada, April 30-May 6, 2005.
  27. Modjarrad K, Zulu I, Redden D, Njobvu L, Lane H, Bentwich Z, Vermund S. Treatment of intestinal helminths does not reduce plasma concentrations of HIV-1 RNA in co-infected Zambian adults. 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 22-26, 2005; Abstract 633.
  28. Stringer JSA, Zulu I, Chi B, Stringer E, Levy J, Chisembele-Taylor A, Mwale A, Bolton C, Saag M, Reid S, Wilfert C, Bulterys M, Goldenberg R, Luhanga D, Sinkala M. Rapid deployment of antiretroviral therapy (ART) services is feasible and effective in resource-limited settings in sub-Saharan Africa. 12th Conference on Retroviruses and Opportunistic Infections, Boston, MA, February 22-26, 2005; Abstract 638b.
  29. * Fusco H, Chi BH, Sinkala M, Stringer JSA. Cost and enrollment implications of different target populations in the rapid scale-up of antiretroviral treatment programs. XV International AIDS Conference in Bangkok, Thailand, July 11-16, 2004; Abstract WeOrB1281.
  30. Sinkala M, Chi BH, Stringer EM, Ng’uni C, Myzece E, Stringer JSA. Employment of off-duty staff as a strategy to meet the human resource needs of an expanding PMTCT program in Zambia. XV International AIDS Conference in Bangkok, Thailand, July 11-16, 2004; Abstract WePeE6761.
  31. Stringer EM, Sinkala M, Ng’uni C, McFarlane Y, Chipimo M, Myzece E, Chi BH, Stringer JSA. In an urban African setting, the cost-effectiveness of PMTCT services improves as services expand. XV International AIDS Conference in Bangkok, Thailand, July 11-16, 2004; Abstract TuPeC4933.
  32. Stringer JSA, Maclean CC, Chansa K, DeGroot A, Stringer EM, Goldenberg RL, Chipimo M, Acosta E, Vermund SH, Kankasa C, Sinkala M. Population effectiveness of a city-wide program to prevent mother-to-child transmission in Lusaka, Zambia XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract ThPeC7287.
  33. Wamulume C, Stringer EM, Luhanga D, Makuka I, Goldenberg RL, Simwanza M, Levy J, Stringer JSA, Sinkala M. Care and treatment of HIV-infected families is feasible in Lusaka, Zambia. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract ThPeB7085.
  34. Makuka I, Sinkala M, Wamulume C, Luhanga D, Sorter S, Worley S, Stringer EM, Rabkin M. Use of peer educators in an ARV treatment program in Lusaka, Zambia. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract ThPeB7277.
  35. Kaseba CM, Stringer EM, Sinkala M, Matongo I, Goldenberg RL, Chapman V, Mulenga H, Stringer JSA. Short-term safety and acceptability of the intrauterine contraceptive device in HIV-infected postpartum women: a randomised trial. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract ThPeB7073.
  36. Levy JW, Kaseba CM, Matongo I, Mulenga H, Stringer JSA, Stringer EM. Natural history of HIV in a cohort of recently postpartum women and their infants in Lusaka, Zambia. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract ThPeC7313.
  37. Kolsky R, O’Meara T, Lubasi T, Fusco H, Sinkala M, Stringer JSA. Challenges of PMTCT program implementation in rural Zambia. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract WePeE6778.
  38. Kafulafula G, Martinson F, Msamanga G, Sinkala M. Phase III trial of antibiotics to reduce chorioamnionitis-associated MTCT of HIV. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract ThOrC1418.
  39. Stringer JSA, Degroot A, Kankasa C, Maclean CC, Chipimo M, Stringer EM, Levy J, Goldenberg RL, Vermund SH, Acosta EP, Sinkala M. HIV prevalence and incident seroconversion in an urban African obstetric population. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract MoPeC3597.
  40. McFarlane Y, Sinkala M, Luhanga D, Wamulume C, Stringer EM. A World Food Program donation to the MTCT Plus Family ARV Center at Chelstone Clinic in Lusaka, Zambia. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract TuPe5285.
  41. Maclean CC, Stringer JSA. Potential cost-effectiveness of maternal and infant antiretroviral interventions to prevent MTCT during breastfeeding. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract TuPeC4928.
  42. Chi BH, Thierman S, Levy J, Sinkala M, Mukuka I, Degroot A, Stringer EM, Goldenberg RL, Stringer JSA. Predictors of HIV testing acceptance among antenatal clinic attendees in Lusaka, Zambia. XV International AIDS Conference, Bangkok, Thailand, July 11-16, 2004; Abstract ThPeC7303.
  43. Stringer JSA, Sinkala M, Goldenberg RL, Acosta EP, Kumwenda R, Chapman V, Vermund SH. Maximizing nevirapine coverage to prevent perinatal HIV transmission in high-prevalence, resource poor settings. XIV International AIDS Conference; Barcelona, Spain. July 7-12, 2002; Abstract WePeB5935.
  44. * Stringer EM, Chapman V, Stringer J, Sinkala M, Kumwenda R, Vermund S, Goldenberg R. HIV Knowledge does not predict risky behavior in an obstetrical population in Lusaka, Zambia. XIV International AIDS Conference; Barcelona, Spain. July 7-12, 2002; Abstract MoPpD2024 (oral poster presentation)
  45. Stringer EM, Stringer JSA, Chapman V, Sinkala M, Vermund S, Kumwenda R, Goldenberg R. HIV risk perception does not correlate with actual HIV status in post-partum women in Zambia. XIV International AIDS Conference; Barcelona, Spain. July 7-12, 2002; Abstract WePeD6392.
  46. Stringer JSA, Mudenda V, Sinkala M, Vermund SH, Stout JP, Kumwenda R, Mwinga K, Goldenberg RL. Acute and Chronic Inflammation of the Fetal Membranes and Risk of Perinatal HIV Transmission in the Setting of Nevirapine Prophylaxis. 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants; Kampala, Uganda. September 9-13. Abstract 248.
  47. * Stringer JSA, Sinkala M, Goldenberg RL, Stout JP, Acosta EP, Kumwenda R, Cliver S, Aldrovandi GM, Mwinga K, Vermund SH. A prospective comparison of two strategies for perinatal nevirapine administration in Zambia. 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants; Kampala, Uganda. September 9-13. Abstract 303.
  48. Stringer JSA, Sinkala M, Goldenberg RL, Stout JP, Kumwenda R, Mwinga K, Aldrovandi G, Vermund SH. A pilot study of nevirapine administered upon presentation in labor without HIV testing. 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants; Kampala, Uganda. September 9-13. Abstract 300.
  49. Sinkala M, Kwapa P, Chilufya M, Haworth A, Stout J, Stringer JSA, Vermund SH. Knowledge, satisfaction, and informed consent in nevirapine administration among nurse-midwives and postpartum women in Lusaka, Zambia. 3rd Conference on Global Strategies for the Prevention of HIV Transmission from Mothers to Infants; Kampala, Uganda. September 9-13. Abstract 404.
  50. * Stringer JSA, Rouse DJ, Stinnett AA, Sinkala M, Goldenberg RL, Vermund SH. For women in prenatal care, choice of the optimal perinatal nevirapine strategy hinges critically upon patient adherence. XIII International AIDS Conference, Durban South Africa. 9-14 July, 2000. Abstract ThPpC1445.
  51. * Stringer JSA, Stinnett AA, Rouse DJ, Sinkala M, Goldenberg RL, Vermund SH. Cost-effectiveness of two novel strategies of perinatal nevirapine administration for women who deliver preterm or lack prenatal care. XIII International AIDS Conference, Durban South Africa. 9-14 July, 2000. Abstract: C-620.
  52. * Stringer JSA, Rouse DJ. Rapid testing and zidovudine treatment to prevent vertical transmission of Human Immunodeficiency Virus in unregistered obstetrical patients: a cost-effectiveness and cost-benefit analysis. 19th Annual Meeting of the Society for Maternal-Fetal Medicine. Abstract #16 Am J Obstet Gynecol 1999: S7.